The page is the record's research on the issuer — no analyst, no rating, no view.

# Dare Bioscience, Inc. (NASDAQ: DARE) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Dare Bioscience, Inc., listed on NASDAQ under ticker DARE, with ISIN US23666P2002. The LEI is not on the record, as there is no GLEIF record with the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.

## The disclosure read

The record holds 71 filings in the twelve months to 2026-11-08, across 51 filing days. The median gap between filing days is 6.0 days. The latest filing is dated 2026-10-27 and is of type agm_egm. The latency from the latest filing to the record date is 12 days. The NASDAQ peer median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4359 issuers. The 2834 Pharmaceutical Preparations peer median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days across 526 issuers.

## Auditor

The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

## Open research

No openly published research notes were found on the record. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001401914.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NASDAQ/DARE (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/DARE (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/DARE · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp